We speculate that the Pep-1@PDA-TMZ NPs could be targeted to GBM via IL-13Rα2-mediated endocytosis, However, the specific transmembrane mechanisms of Pep-1 carried NPs need to be further explored in the future research, including the involvement of other signaling pathways. The gene discussed is IL13RA2; the disease is glioblastoma.